Please use this identifier to cite or link to this item:
Title: Sublingual immunotherapy: World Allergy Organization position paper 2013 update
Authors: Giorgio Walter Canonica
Linda Cox
Ruby Pawankar
Carlos E. Baena-Cagnani
Michael Blaiss
Sergio Bonini
Jean Bousquet
Moises Calderón
Enrico Compalati
Stephen R. Durham
Roy Gerth Van Wijk
Désirée Larenas-Linnemann
Harold Nelson
Giovanni Passalacqua
Oliver Pfaar
Nelson Rosário
Dermot Ryan
Lanny Rosenwasser
Peter Schmid-Grendelmeier
Gianenrico Senna
Erkka Valovirta
Hugo Van Bever
Pakit Vichyanond
Ulrich Wahn
Osman Yusuf
Universita degli Studi di Genova
Nova Southeastern University
Nippon Medical School
Catholic University
University of Tennessee Health Science Center
Universita degli Studi di Napoli Federico II
CHU Montpellier
Royal Brompton Hospital
National Heart and Lung Institute
Erasmus University Medical Center
Hospital Medica Sur
University of Colorado School of Medicine
Ospedale Policlinico San Martino
Universitatsklinikum Mannheim
Universidade Federal do Parana
University of Aberdeen
University of Missouri-Kansas City
University Hospital Zurich, Dermatologische Klinik
Verona General Hospital
National University of Singapore
Turun yliopisto
Mahidol University
Humboldt-Universitat zu Berlin
Allergy and Asthma Institute
Keywords: Immunology and Microbiology;Medicine
Issue Date: 28-Mar-2014
Citation: World Allergy Organization Journal. Vol.7, No.1 (2014)
Abstract: © 2014 Canonica et al.; licensee BioMed Central Ltd. We have prepared this document, "Sublingual Immunotherapy: World Allergy Organization Position Paper 2013 Update", according to the evidence-based criteria, revising and updating chapters of the originally published paper, "Sublingual Immunotherapy: World Allergy Organization Position Paper 2009", available at. Namely, these comprise: "Mechanisms of sublingual immunotherapy;" "Clinical efficacy of sublingual immunotherapy" - reporting all the data of all controlled trials published after 2009; "Safety of sublingual immunotherapy" - with the recently published Grading System for adverse reactions; "Impact of sublingual immunotherapy on the natural history of respiratory allergy" - with the relevant evidences published since 2009; "Efficacy of SLIT in children" - with detailed analysis of all the studies; "Definition of SLIT patient selection" - reporting the criteria for eligibility to sublingual immunotherapy; "The future of immunotherapy in the community care setting"; "Methodology of clinical trials according to the current scientific and regulatory standards"; and "Guideline development: from evidence-based medicine to patients' views" - including the evolution of the methods to make clinical recommendations. Additionally, we have added new chapters to cover a few emerging crucial topics: "Practical aspects of schedules and dosages and counseling for adherence" - which is crucial in clinical practice for all treatments; "Perspectives and new approaches" - including recombinant allergens, adjuvants, modified allergens, and the concept of validity of the single products. Furthermore, "Raising public awareness about sublingual immunotherapy", as a need for our patients, and strategies to increase awareness of allergen immunotherapy (AIT) among patients, the medical community, all healthcare stakeholders, and public opinion, are also reported in detail.
ISSN: 19394551
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.